Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
| Revenue (TTM) | $279.99M |
| Gross Profit (TTM) | $99.72M |
| EBITDA | $5.43M |
| Operating Margin | -5.38% |
| Return on Equity | 4.64% |
| Return on Assets | -1.48% |
| Revenue/Share (TTM) | $2.10 |
| Book Value | $1.97 |
| Price-to-Book | 0.71 |
| Price-to-Sales (TTM) | 0.69 |
| EV/Revenue | 0.935 |
| EV/EBITDA | 34.22 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 48.70% |
| Shares Outstanding | $136.34M |
| Float | $55.27M |
| % Insiders | 29.68% |
| % Institutions | 8.87% |